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Ltd. This is an open access article unAbstract The sense of smell is largely taken for granted by laypersons and medical profes-
sionals alike. Indeed, its role in determining the flavor of foods and beverages, as well as in
warning of, or protecting against, environmental hazards, often goes unrecognized. This is
exemplified, in part, by the fact that most patients presenting to medical clinics with “taste”
problems are typically subjected to complex brain imaging and gastroenterological tests
without the sense of smell even being tested or considered as a basis of the problem. Aside
from frank deficiencies in sweet, sour, bitter, salty and savory (umami) sensations, “taste” dis-
orders most commonly reflect inadequate stimulation of the olfactory receptors via the retro-
nasal route; i.e., from volatiles passing to the receptors from the oral cavity through the nasal
pharynx. This article describes the two most common procedures for measuring the sense of
smell in the clinic and provides examples of the application of these tests to diseases and other
disorders frequently associated with smell loss. Basic issues related to olfactory testing and
evaluation are addressed. It is pointed out that smell loss, particularly in later life, can be a
harbinger for not only a range of neurodegenerative diseases, but can be a prognostic indicator
of early mortality.
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Olfactory dysfunction 29Introduction
Smell loss or distortion is a common problem encountered
by the otolaryngologist. Such dysfunction is often reflected
in complaints of “taste” loss, with many patients noting
that food “tastes like cardboard” or no longer has hedonic
appeal. Diminished smell sensitivity influences food selec-
tion and nutrient intake, and compromises safety from food
poisoning and toxic agents. Indeed, a disproportionate
number of the elderly die in fires, gas explosions, and toxic
exposures as a result of being unable to detect smoke or
odorous warning agents added to natural gas.1 Smell
dysfunction can be devastating for those who depend upon
this sense for their safety or livelihood, such as cooks,
homemakers, plumbers, fire fighters, perfumers, fragrance
sales persons, wine merchants, food and beverage distrib-
utors, and employees of numerous chemical, gas, and
public works industries. Indeed, according to medical reg-
ulations, anosmics are not allowed into the U.S. armed
forces, reflecting the importance of smell function in the
operation of complex machinery and the potential for ex-
posures to toxic agents in the battlefield.
As is the case with vision and hearing, quantitative
testing is essential to (a) determine the validity and nature
of a patient’s complaint, (b) accurately monitor changes in
function over time (including influences of pharmacolog-
ical, surgical, or immunological interventions), (c) detect
malingering, and (d) establish disability compensation.
Fortunately, largely as a result of funding from the U.S.
National Institutes of Health in the early 1980’s, significant
advances have been made in the development and appli-
cation of easy-to-use and reliable clinical tests of olfactory
function e advances described in this paper. It is clearly is
no longer tenable to simply ask a patient whether a few
odorants placed under the nose can be identified, since this
approach can result in misleading conclusions, as it is not
quantifiable, lacks reliability, has no normative referent,
and is easily faked by malingerers.
Basic considerations in measuring smell
function
The sense of smell is sensitive to thousands, if not millions,
of odorants. While accurate testing of such a sense ap-
pears, at first glance, to be daunting, smell function is
relatively easy to measure. Thus, with some exceptions,
when psychophysical thresholds are increased to one
odorant they tend to be increased to others, reflecting the
commonality and distribution of the receptor cells and their
propensity for injury.2 Analogous phenomena are present
for the identification of different odorants. Injury to more
central neural structures similarly influences pathways that
code or transmit information from more than one class of
receptor cell. For these reasons, responses to only a few
well-chosen target odorants need to be evaluated to
establish an accurate assessment of the overall functioning
of the system. The reader is referred elsewhere for
detailed information on the anatomy and physiology of the
olfactory system.3
In recent years, both psychophysical and electrophysio-
logical tests have been developed to quantify olfactoryfunction in the clinical setting. Additionally, modern
structural and functional imaging procedures have been
applied to better define the underpinnings of functional
losses, such as damage to or the lack of olfactory bulbs and
tracts.4 However, olfactory tests vary in terms of sensitivity
and practicality, ranging from brief tests of odor identifi-
cation to sophisticated olfactometers yoked to electro-
physiological recording equipment capable of quantifying
odor-induced changes in electrical activity at the level of
the olfactory epithelium (the electro-olfactogram; EOG)
and cortex (odor event-related potentials; OERPs). Psy-
chophysical tests are more practical and less costly than
electrophysiological tests, making them much more popu-
lar, particularly in light of technical issues with electro-
physiological testing. For example, the EOG cannot be
reliably measured in all patients, given epithelial sampling
issues and the intolerance of some subjects to electrodes
that are placed within their non-anesthetized noses. Since
the EOG is present in some anosmics and can be recorded
even after death, it cannot be used, by itself, as a reliable
indicator of general olfactory function. Unlike the auditory
brainstem evoked potential, the OERP is presently inca-
pable of localizing anomalies within the olfactory path-
ways. OERP recording sessions can be quite long since
relatively long inter-stimulus intervals are needed to pre-
vent adaptation.5
Some physicians, as well as attorneys seeking to deni-
grate psychophysical test results, divide sensory tests into
“subjective” and “objective” classes. The former require a
conscious response on the part of the examinee, whereas
the latter assess involuntary reactions, such as altered
electrical or autonomic nervous system activity. However,
as pointed out for audition by the Nobel laureate Georg von
Bekesy nearly 50 years ago, such a dichotomy is misleading
and laden with a value judgment, since objective always
trumps subjective.6 In fact, most psychophysical olfactory
tests provide a more sensitive assessment of function than
do electrophysiological measures. While it is presumed that
“subjective” tests are easier to malinger than “objective”
tests, forced-choice psychophysical tests can detect most
malingerers on the basis of improbable responses,7 and
many so-called “objective” olfactory tests are not immune
to malingering. For example, reliable measurement of
electrophysiological responses requires considerable sub-
ject cooperation, such as sitting very still during recording
sessions.Modern psychophysical olfactory tests
The utility of a clinical olfactory test depends upon its
reliability (consistency, stability), validity (accuracy in
measuring dysfunction), and practicality (administration
time and effort). Related to its validity are its sensitivity
(ability to detect abnormalities), specificity (ability to
detect abnormalities with a minimum of false positives),
and positive predictive value (the proportion of all positive
tests that are true positives). Unfortunately, too few data
are available to allow for statistically valid comparative
assessment of such parameters among the dozens of ol-
factory tests that are presently available,2 although, in
general, the more trials contained in a test, the higher its
30 R.L. Dotyreliability and sensitivity8; see Fig. 1. Even though some
very short olfactory tests are statistically reliable, such
reliability comes at a price of lessened sensitivity or spec-
ificity, as brief tests can only clump patients into very broad
dysfunction categories. This is analogous to the difficulty of
using of a flashlight to determine differing degrees of visual
disturbances, ultimately limiting classifications to total
blindness or lack of total blindness.
Most modern clinical tests of olfactory function assess
odor identification, threshold detection, discrimination, or
memory.2 It should be noted, however, that such nominally
disparate tests are not mutually exclusive and generally
correlate with one another. At our center we largely rely
upon forced-choice odor identification and single staircase
detection threshold tests for assessing dysfunction in pa-
tients, as they are reliable and conceptually measure
somewhat different elements of olfactory processing.
These tests are briefly described below, followed by ex-
amples of their application to clinical disorders.Fig. 1 Relationship of reliability to cumulative test length for te
are indicated. Modified from Doty et al. (1995). Copyrightª 1995 OOdor identification: The University of Pennsylvania
Smell Identification Test (UPSIT)
The UPSIT, developed in the early 1980’s, was derived from
basic test measurement theory and focuses on the
comparative ability of individuals to identify odors at the
suprathreshold level.9 Its popularity is due, in large part, to
its high sensitivity, reliability (testeretest r Z 0.94), and
practicality, such as its ability to be self-administered in a
waiting room inw10 min and scored by a technician, nurse,
or secretary in less than a minute. Physically it is comprised
of four test booklets, each containing 10 pages (Fig. 2). A
strip embedded with a microencapsulated odorant is pre-
sent on the bottom of each page, just below a four-
alternative multiple choice question. For a given item,
the patient releases an odor by scratching the micro-
encapsulated pad with a pencil tip, smells the pad, and
indicates the odor quality from four alternatives. Even if no
smell is perceived, a response is required (i.e., the test isst measures amenable to such an evaluation. Best fit formulae
xford University Press.
Fig. 2 The University of Pennsylvania Smell Identification
Test. This 40-odorant self-administered test consists of four 10-
page booklets. Each page contains a different “scratch and
sniff” scented strip and an associated multiple choice ques-
tion. The stimuli are released using a pencil tip.
Photo courtesy of Sensonics International, Haddon Hts., NJ
08035, USA. Copyrightª 2000 Sensonics International.
Fig. 3 The Snap and Sniff Threshold Test. This modern test
allows for rapid and reliable determinations of detection
thresholds. Concentrations of phenyl ethyl alcohol, ranging from
102 to 109 log vol/vol in half-log concentration steps are
commonly employed, alongwith blanks for forced-choice testing.
Photocourtesy of Sensonics International,HaddonHts., NJ08035,
USA. Copyrightª 2015, Sensonics International.
Olfactory dysfunction 31forced-choice). An answer column for each item is located
on the back of the test booklet, and the subject’s total
correct score out of the 40 items is determined. This score
is then compared to a normative database from nearly 4000
normal individuals, providing an indication of the level of
absolute smell function (i.e., normosmia, mild hyposmia,
moderate hyposmia, severe hyposmia, total anosmia) and a
percentile rank for each age and gender group. Malingering
is detected on the basis of improbable responses.
The UPSIT was the impetus for a massive smell function
survey sent to nearly 11 million subscribers of the National
Geographic Magazine in 1986.10 The UPSIT and its shorter
versions [e.g., the 4-item Pocket Smell Test (PST) and the
12-item Brief Smell Identification Test (B-SIT)] have been
administered to nearly a million persons worldwide and are
the basis for the smell testing that has been incorporated
into the current National Health and Nutrition Examination
Survey of the United States (NHANES).11 This survey peri-
odically assesses the health and nutritional status of the
American population. The UPSIT has now been adapted to
multiple cultures and is available in languages in addition to
English, including Arabic, Afrikan, Chinese (both simplified
and classical), Czechoslovakian, Dutch, French, German,
Hungarian, Italian, Japanese, Polish, Portuguese, Spanish,
Swedish, and Turkish.
Olfactory threshold testing: the single staircase
odor detection threshold test
Olfactory threshold tests are analogous to pure-tone audi-
tory threshold tests in that their goal is to detect the lowest
amount of stimulus a subject can discern. In the early
1970’s, I developed a staircase procedure for assessing smell
thresholds based upon a paradigm I had used in vestibular
psychophysics at the North American Space Administration’s
Ames Research Center at Moffett Field, California (NASA).12
In this staircase test, the concentration of an odorant is
increased following trials on which a subject fails to detect
the stimulus and decreased following trials where correctdetection occurs, and an average of a set of upedown
transitions (“reversals”) is used to estimate the threshold
value.13 This provides a much more reliable estimate of
threshold than procedures in which only a single ascending
or descending series of stimuli is employed,14 and is much
less time consuming than procedures that present large
numbers of trials at each of a number of concentrations
(e.g., the method of constant stimuli).2 The patient is
required to indicate which of two or more stimuli (i.e., an
odorant and one or more blanks) seems strongest on a given
trial, rather than to simply report the presence or absence of
a smell, mitigating the influences of response biases (e.g.,
the conservatism or liberalism in reporting the presence of
an odor under uncertain conditions) on the sensitivity mea-
sure. Forced-choice testing is critical for threshold testing,
as it controls for a subject’s response bias or criterion for
responding, i.e., liberalism or conservatism in reporting the
presence of a stimulus independent of the subject’s actual
sensory sensitivity. The response criterion is confounded
with the measure of sensitivity when forced-choice pro-
cedures are not employed, as discussed in detail elsewhere.2
A modern example of an olfactory test system utilizing
the single staircase paradigm is physically comprised of a
series of “snap and sniff” wands that allow for rapid pre-
sentation of concentration series of various odorants
(Fig. 3).15 Liquids, per se, are not present in the wands, as
the odorants are embedded in an absorbent material
exposed to the air when the collar on the outside of the
wand is moved forward. This reliable test provides a stan-
dardized means for assessing sensitivity to such stimuli as
amyl (pentyl) acetate, n-butanol, and phenyl ethyl alcohol
(PEA), the latter being preferred. PEA is an odorant with a
rose-like smell at higher concentrations and little or no
intranasal trigeminal nerve (Cranial Nerve V) reactivity.16 In
this test, concentrations of PEA ranging from 9.00 to
2.00 log10 units in half-log steps are presented, with
comparisons being made on each trial with a blank stim-
ulus. While most threshold tests require considerable time
to administer in order to obtain reliable results, this test
can obtain a reliable threshold in 10e12 min.
32 R.L. DotyFindings from the application of quantitative
olfactory tests
The majority of major discoveries involving human olfac-
tory function in the modern era have been made using the
UPSIT. Among the non-clinical basic discoveries that have
resulted from the administration of this test are the
following: (a) women, on average, have a better sense of
smell than men, and this superiority is noticeable as early
as four years of age, increases in the later years of life, and
is culture independent,17,18 (b) there is a substantial ge-
netic influence on the ability to identify odors,19 although
environmental factors likely overcome this influence later
in life,20 (c) major loss of olfactory function occurs after
the age of 65 years, with over half of those between 65 and
80 years of age, and over three-quarters of those 80 years
of age and older, having such loss,17 (d) the decrement in
olfactory function associated with smoking is present in
past smokers and recovery to pre-smoking levels, while
possible, can take years, depending upon the duration and
amount of past smoking,21 and (e) olfactory function is
compromised in urban residents and in workers in some
industries, including the paper and chemical manufacturing
industries.22e26
Clinical applications of the UPSIT have also led to
important discoveries. Thus, it is now apparent that about
15% of patients with significant head trauma, particularly
cases where marked coup contra coup movement of the
brain has occurred, exhibit demonstrable smell loss, often
total anosmia,27 and is typically associated with a reduction
in the size of the olfactory bulbs and tracts.28 Smell loss is
now known to be common in schizophrenia and related
diseases and, unlike neuropsychological measures, corre-
lates with disease duration, suggesting the presence of a
progressive, perhaps neurodegenerative, component of this
disease that has previously gone unrecognized.29 Marked
smell dysfunction has now been documented for myas-
thenia gravis, an autoimmune disorder previously believed
to be solely a peripheral disease of the cholinergic motor
endplate, suggesting the likelihood of a significant CNS
component.30 Among the more important observations that
followed the development of the UPSIT was the discovery
that smell loss can be a very early sign e perhaps the
earliest sign e of such serious neurological diseases as
Alzheimer’s disease (AD), Huntington’s disease, and idio-
pathic Parkinson’s disease (PD).31 Indeed, smell testing can
be a useful aid in detecting the early pre-clinical period of
such diseases when yet-to-be-developed pharmacologic
interventions will likely be most effective. Since some
neurodegenerative disorders often misdiagnosed as AD or
PD exhibit little or no olfactory dysfunction [e.g., major
affective disorder and progressive supranuclear palsy (PSP),
respectively], olfactory testing can also be employed in
differential diagnosis.32e35 More recently it has been
discovered that impaired odor identification, particularly
in the anosmic range, is associated with significantly
increased mortality in older adults even after controlling
for dementia and medical comorbidity.36
While nasal surgery or systemic corticosteroid therapy
can improve olfactory function in some patients withrhinosinusitis, polyposis, or other forms or elements of
nasal disease, this is not true for all patients.37 In a pro-
spective trial of 111 patients with medically refractive
chronic rhinosinusitis,38 found that endoscopic nasal sinus
surgery improved olfactory function primarily for anosmic
patients with nasal polyps. Soler, Sauer et al.39 also present
evidence that such surgery was most effective in anosmic
patients with polyps.40 found the degree of olfactory loss,
as measured by the UPSIT, in patients with chronic rhino-
sinusitis to be correlated with the severity of histopatho-
logical changes within the olfactory mucosa. Lymphocytes,
macrophages, and eosinophils release inflammatory medi-
ators that trigger the activation of enzymes critical to the
apoptotic process (e.g., caspase-3). Disease-related dam-
age to the receptor cells of patients with rhinosinusitis was
previously found by Feron, Perry et al.41 Moreover, nasal
biopsies from the posterior superior turbinate, posterior
medial turbinate, and posterodorsal septum of patients
with nasal disease were less likely to contain olfactory
neuroepithelium than analogous biopsies from patients
with no such disease. Others have similarly noted that ol-
factory epithelial biopsies of anosmic patients with rhino-
sinusitis contain less olfactory epithelial tissue than those
from non-anosmic rhinosinusitis patients (27% vs 61% posi-
tive biopsies, respectively).42 Although damage within the
epithelium was noted in rhinosinusitis patients with normal
smell function, such damage was greater in anosmic pa-
tients for whom some olfactory epithelium was able to be
located. Abnormalities in the arrangement of the epithelial
cell types were common in the biopsies from the anosmics
and, when identifiably, the olfactory epithelium was typi-
cally atrophic and thin, largely being comprised of mainly
sustentacular cells and basal cells.
Conclusions
It is relatively easy to quantitatively assess olfactory func-
tion in the clinic. In this brief paper I describe the two most
practical, valid, and influential procedures for achieving
this end, along with a range of clinical findings based upon
their application. The development of such olfactory tests
has been a milestone in the history of rhinology, leading to
the realization that olfactory loss accompanies a much
broader array of medical conditions than previously
appreciated. For example, it is now apparent that smell
loss is among the earliest pre-clinical signs of such common
neurodegenerative diseases as Alzheimer’s and Parkinson’s,
with the attendant implications for potentially effective
prophylactic or mitigative interventions. The categoriza-
tion of olfactory tests into “subjective” and “objective”
categories is misleading, since so-called subjective tests,
when quantifiable, are often more reliable and sensitive
than so-called objective tests. Accurate olfactory assess-
ment requires that an olfactory test is both reliable and
sensitive. In general, test length correlates with test reli-
ability. With the exception of severe airway blockage,
meaningful relationships between airway patency and
quantitative measures of olfactory dysfunction are rare.
This observation, along with histopathological studies,
point to the importance of accurately assessing smell
Olfactory dysfunction 33function in patients before and after medical or surgical
interventions.Disclosure
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